NDC 70835-1001 - Cubicin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70835-1001
Package NDCs from labels
70835-1001-2
Manufacturer
Curia New Mexico, LLC
Effective date
2024-10-14
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cubicin - Curia New Mexico, LLCCuria New Mexico, LLC2024-10-14HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70835-1001-2Cubicin350 mg in 1 VIALINJECTION3504

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70835-1001CUBICIN (DAPTOMYCIN) INJECTION [CURIA NEW MEXICO, LLC]41 package rows20241016_3ca56472-49e1-593d-e054-00144ff8d46c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 3 · 47 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DaptomycinDAPTOMYCINBiocon Pharma Inc.914d4040-eb29-cda5-75e9-95060aa4fe6d2025-08-29Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
daptomycinDAPTOMYCINBE Pharmaceuticals Inc.c305bc9f-8aeb-40de-8492-154929764daf2025-08-29Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINPar Health USA, LLCc1d47001-5e0f-46a3-b220-53f46b4fd6ac2025-08-19Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
daptomycinDAPTOMYCINMylan Institutional LLC95909792-972b-4c0c-b2ce-2be4bed36cff2025-08-15Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINHikma Pharmaceuticals USA Inc.6aa6300a-f59b-4260-b021-8a02cfaeabb72025-07-30Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINMAIA Pharmaceuticals, Inc.d87bd6b5-bf92-49c1-879b-dc2add3deae62025-07-16Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINDr.Reddy's Laboratories Inc.,7e9a1b82-f2ba-b2a4-619c-bea7768263e12025-06-30Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINQilu Pharmaceutical Co., Ltd.e32c7141-fbd9-47c8-bd1e-94b880b2c5a62025-06-16Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
daptomycinDAPTOMYCINSintetica US LLC0e55bfa7-7dbf-4fa1-8aee-eac3fe4e05e32025-02-07Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
24754515-5d97-3638-e063-6294a90a7d063ca56472-49e1-593d-e054-00144ff8d46c2024-10-14Exact identifier
spl id: 24754515-5d97-3638-e063-6294a90a7d06
spl set id: 3ca56472-49e1-593d-e054-00144ff8d46c
DaptomycinDAPTOMYCINXellia Pharmaceuticals USA LLC5e1f739a-eb81-43d8-9a14-89f32b7e1ba12024-05-24Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINXellia Pharmaceuticals USA LLC97c47c18-985d-4373-88f7-a86ec591ea442024-04-08Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINCivica, Inc.bcacf746-a3ee-48b5-bfbe-6a2b548ad24c2024-04-05Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINAPOTEX CORP.4bf6cd85-dfc8-44d4-b569-3ff27b9d3c092024-01-19Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINXellia Pharmaceuticals USA LLC494b2aa1-020b-432c-977e-a5d74e31e3422023-11-17Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
daptomycinDAPTOMYCINHainan Poly Pharm., Co., Ltd.6ec53f7e-9a5f-4b24-84e9-c94325750e322023-11-14Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINCivica, Inc.b1569dbe-7876-481e-bc1c-9c9dd85c49732023-11-13Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DAPTOMYCINDAPTOMYCINEugia US LLC353bfcaa-a0ff-47ab-829a-35ca340f6a082023-09-25Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINXellia Pharmaceuticals USA LLCfc7eef03-042b-44a1-a344-1fa8a04359002023-08-04Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK
DaptomycinDAPTOMYCINNorthStar RxLLC01f3f32a-fac1-4a8f-b205-4601046f0b5c2023-04-19Warnings, Adverse reactionsExact identifier
unii: NWQ5N31VKK

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.